Bioline Rx reported $28.52M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Arca Biopharma USD 395.25M 51.39M Mar/2026
Bio Path USD 677K 14K Mar/2026
Bioline Rx USD 28.52M 3.34M Sep/2025
Capricor Therapeutics USD 283.09M 39.85M Mar/2026